Reduced LHFPL3-AS2 lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 04 08 2023
accepted: 21 11 2023
medline: 24 11 2023
pubmed: 23 11 2023
entrez: 22 11 2023
Statut: epublish

Résumé

Disruption of intestinal epithelial functions is linked to Crohn disease (CD) pathogenesis. We identified a widespread reduction in the expression of long non-coding RNAs (lncRNAs) including LHFPL3-AS2 in the treatment-naïve CD ileum of the RISK pediatric cohort. We validated the reduction of LHFPL3-AS2 in adult CD and noted a further reduction in patients with more severe CD from the RISK cohort. LHFPL3-AS2 knockdown in Caco-2 cells robustly affected epithelial monolayer morphogenesis with markedly reduced confluency and spreading, showing atypical rounding, and clumping. mRNA-seq analysis of LHFPL3-AS2 knockdown cells highlighted the reduction of genes and pathways linked with apical polarity, actin bundles, morphogenesis, and the b-catenin-TCF4 complex. LHFPL3-AS2 knockdown significantly reduced the ability of cells to form an internal lumen within the 3-dimensional (3D) cyst model, with mislocalization of actin and adherent and tight junction proteins, affecting epithelial polarity. LHFPL3-AS2 knockdown also resulted in defective mitotic spindle formation and consequent reduction in epithelial proliferation. Altogether, we show that LHFPL3-AS2 reduction affects epithelial morphogenesis, polarity, mitotic spindle formation, and proliferation, which are key processes in maintaining epithelial homeostasis in CD. Reduced expression of LHFPL3-AS2 in CD patients and its further reduction with ileal ulceration outcome, emphasizes its significance in this context.

Identifiants

pubmed: 37993670
doi: 10.1038/s41598-023-47997-7
pii: 10.1038/s41598-023-47997-7
pmc: PMC10665440
doi:

Substances chimiques

RNA, Long Noncoding 0
Actins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20513

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK078392
Pays : United States
Organisme : European Research Council
ID : 758313
Pays : International

Informations de copyright

© 2023. The Author(s).

Références

Inflamm Bowel Dis. 2018 Jan 18;24(2):346-360
pubmed: 29361088
Cold Spring Harb Perspect Biol. 2017 Jul 5;9(7):
pubmed: 28213466
Nat Cell Biol. 2007 Feb;9(2):160-70
pubmed: 17330329
Mol Biol Cell. 2016 Feb 15;27(4):617-26
pubmed: 26680741
J Cell Biol. 1999 Feb 22;144(4):687-99
pubmed: 10037790
Oncol Rep. 2020 Dec;44(6):2503-2516
pubmed: 33125127
J Cell Sci. 2006 Oct 15;119(Pt 20):4155-63
pubmed: 17038542
Int J Oncol. 2011 May;38(5):1365-73
pubmed: 21369697
EMBO J. 2012 Nov 28;31(23):4415-27
pubmed: 23103768
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
J Physiol Biochem. 2008 Dec;64(4):377-82
pubmed: 19391463
J Cell Biol. 2001 May 28;153(5):1049-60
pubmed: 11381089
Int J Radiat Oncol Biol Phys. 1992;22(3):613-7
pubmed: 1346533
Biol Bull. 2008 Jun;214(3):218-32
pubmed: 18574100
J Cell Biol. 2005 Dec 19;171(6):1061-71
pubmed: 16344308
J Clin Invest. 2014 Jul;124(7):2947-62
pubmed: 24892806
Gastroenterology. 2021 Dec;161(6):1924-1939
pubmed: 34478742
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W96-102
pubmed: 20484371
J Cell Biol. 2008 Nov 17;183(4):625-33
pubmed: 19001128
Cell. 2008 Nov 28;135(5):865-78
pubmed: 19041750
Gastroenterology. 1989 Mar;96(3):736-49
pubmed: 2914637
Traffic. 2018 May 16;:
pubmed: 29766620
J Cell Physiol. 2008 Apr;215(1):182-91
pubmed: 17960592
JCI Insight. 2023 Jul 24;8(14):
pubmed: 37261910
Trends Genet. 2019 Dec;35(12):892-902
pubmed: 31662190
Curr Biol. 2003 Aug 5;13(15):R614-24
pubmed: 12906817
J Clin Invest. 2014 Aug;124(8):3617-33
pubmed: 25003194
Cell Mol Gastroenterol Hepatol. 2022;14(5):1053-1076
pubmed: 35944892
Cell Mol Life Sci. 2013 Dec;70(24):4785-94
pubmed: 23880895
Adv Exp Med Biol. 2005;570:393-421
pubmed: 18727509
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):254-260
pubmed: 27050050
Gut. 2022 Jan 12;:
pubmed: 35022268
Nat Rev Mol Cell Biol. 2014 Apr;15(4):225-42
pubmed: 24651541
Clin Rev Allergy Immunol. 2021 Apr;60(2):164-174
pubmed: 32474815
J Cell Biol. 2005 Jan 17;168(2):221-32
pubmed: 15642749
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
J Cell Biol. 1994 Sep;126(6):1509-26
pubmed: 8089182
Mol Cell Biol. 2016 Apr 15;36(9):1332-41
pubmed: 26884465
Cancer Res. 2018 Oct 15;78(20):5877-5890
pubmed: 30185552
Int J Oncol. 2008 Feb;32(2):377-85
pubmed: 18202760
J Biol Chem. 2011 Apr 8;286(14):12461-74
pubmed: 21300793
Oncogene. 2011 Apr 21;30(16):1956-62
pubmed: 21151178
J Cell Biol. 1994 Jun;125(6):1327-40
pubmed: 8207061
Gastroenterology. 2018 Feb;154(3):585-598
pubmed: 29031501
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21
pubmed: 27848962
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Gastroenterology. 2013 Oct;145(4):808-19
pubmed: 23792201
Am J Gastroenterol. 2002 Apr;97(4):947-53
pubmed: 12003431
J Cell Biol. 1992 Feb;116(4):989-96
pubmed: 1734027
Nature. 2008 Jul 3;454(7200):126-30
pubmed: 18509338
Gut. 1989 Jul;30(7):983-9
pubmed: 2668130
J Crohns Colitis. 2023 Jun 16;17(6):960-971
pubmed: 36655602
Cancer Sci. 2006 Nov;97(11):1217-25
pubmed: 16965391
Curr Biol. 2015 Feb 16;25(4):R162-71
pubmed: 25689915
J Cell Sci. 2009 Dec 1;122(Pt 23):4253-66
pubmed: 19923269
Nat Methods. 2012 Nov;9(11):1069-76
pubmed: 23132118
Genes Dev. 2012 Dec 15;26(24):2709-23
pubmed: 23249734
Int Rev Cytol. 2003;226:127-64
pubmed: 12921237
Microsc Res Tech. 2000 May 15;49(4):353-62
pubmed: 10820519
Gastroenterology. 2007 Aug;133(2):412-22
pubmed: 17681162
J Cell Biol. 2001 Sep 17;154(6):1185-96
pubmed: 11564756
Cancer Lett. 2022 Apr 10;531:1-13
pubmed: 35101541
Annu Rev Physiol. 2020 Feb 10;82:251-273
pubmed: 31618602
Traffic. 2000 Jan;1(1):76-83
pubmed: 11208062
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W305-11
pubmed: 19465376
PLoS Genet. 2013 Mar;9(3):e1003368
pubmed: 23555285
J Biol Chem. 2001 Jan 12;276(2):875-83
pubmed: 11035016
J Cell Biol. 1998 Mar 9;140(5):1039-53
pubmed: 9490718

Auteurs

Katya E Sosnovski (KE)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Tzipi Braun (T)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.

Amnon Amir (A)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.

Marina BenShoshan (M)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Haya Abbas-Egbariya (H)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Rakefet Ben-Yishay (R)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.

Liat Anafi (L)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.

Camilla Avivi (C)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.

Iris Barshack (I)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Lee A Denson (LA)

Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Yael Haberman (Y)

Sheba Medical Center, Tel-Hashomer, Affiliated with the Tel Aviv University, Tel Aviv, Israel. Yael.Haberman@sheba.health.gov.il.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Yael.Haberman@sheba.health.gov.il.
Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Yael.Haberman@sheba.health.gov.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH